Don't Jump to a CGRP Antagonist for Migraine Prophylaxis
You'll see two new biologics to PREVENT migraine in adults, Ajovy (uh-JOH-vee, fremanezumab) and Emgality (em-GAL-ih-tee, galcanezumab).
They'll join Aimovig (erenumab)...the first calcitonin gene-related peptide blocker, or CGRP antagonist. Blocking CGRP limits vasodilation.
All are once-monthly, self-administered subcutaneous injections...or Ajovy can be given as 3 injections once every 3 months. Aimovig is an auto-injector...Ajovy is a prefilled syringe...Emgality is a pen.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote